Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,022 | 0,034 | 18:37 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | 729 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
15.08. | Stagezero Life Sciences Ltd (2): Stagezero Life lists on NEX, remains suspended | 3 | Stockwatch | ||
14.08. | StageZero Life Sciences Ltd.: StageZero Announces Listing on the NEX Exchange | 1 | TheNewswire | ||
14.08. | Stagezero Life Sciences Ltd (2): Stagezero Life Sciences downgraded to NEX | 1 | Stockwatch | ||
25.07. | Stagezero Life Sciences Ltd (2): Stagezero to delist from TSX, applies for NEX listing | 2 | Stockwatch | ||
25.07. | StageZero Life Sciences Ltd.: StageZero Announces Delisting from the TSX and a Concomitant Application for Listing on the NEX Exchange | 1 | TheNewswire | ||
14.05. | Stagezero Life Sciences Ltd (2): Stagezero, ElevationMD use Aristotle to detect cancer | 1 | Stockwatch | ||
13.05. | StageZero Life Sciences Ltd.: StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer | 3 | TheNewswire | ||
STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
07.05. | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Cease Trade Order and Proposed Financing | 4 | TheNewswire |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 45,240 | +3,24 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 47 Euro auf "Hold" belassen. Finanzchef Justus Wehmer habe gute Gründe für mittelfristigen... ► Artikel lesen | |
INTUITIVE SURGICAL | 387,00 | +2,37 % | Opening Bell: Puma, Novo Nordisk, Droneshield, Rio Tinto, Robinhood, Intuitive Surgical | Alle Jahre wieder droht in den USA der Regierungsshutdown. Auch dieses Jahr. Demokraten und Republikaner haben sich noch nicht auf einen Haushalt geeinigt. Auswirkungen an der Börse waren noch nicht... ► Artikel lesen | |
BOSTON SCIENTIFIC | 82,80 | -0,24 % | Piper Sandler bestätigt 'Overweight'-Rating für Boston Scientific | ||
PLUS THERAPEUTICS | 0,730 | +7,76 % | Plus Therapeutics Inc.: Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide Cerebrospinal Fluid Assay for Metastatic CNS Cancer | HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), announced today that it has signed... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,011 | -13,85 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
LIFEWARD | 0,750 | -2,55 % | Lifeward Ltd.: Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
SENSEONICS | 0,400 | +6,88 % | Senseonics Holdings, Inc. - 8-K, Current Report | ||
EKSO BIONICS | 5,680 | +7,58 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 4,440 | -3,90 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
ROCKWELL MEDICAL | 1,032 | +0,39 % | Rockwell Medical promotes Heather Hunter to COO | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
MEMPHASYS | 0,002 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 30.09.2025 | Das Instrument IG7 AU000000MEM5 MEMPHASYS LTD EQUITY wird cum Kapitalmassnahme gehandelt am 30.09.2025 und ex Kapitalmassnahme am 01.10.2025 The instrument IG7 AU000000MEM5 MEMPHASYS LTD EQUITY is traded... ► Artikel lesen | |
VIRIDIAN THERAPEUTICS | 18,405 | +1,60 % | Viridian Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) |